Abstract
Ventilator-associated pneumonia (VAP) is defined as pneumonia that occurs 48–72 hours or thereafter following endotracheal intubation, characterized by the presence of a new or progressive infiltrate, signs of systemic infection (fever, altered white blood cell count), changes in sputum characteristics, and detection of a causative agent [1]. VAP contributes to approximately half of all cases of hospital-acquired pneumonia [1, 2]. VAP is estimated to occur in 9–27 % of all mechanically ventilated patients, with the highest risk being early in the course of hospitalization [1, 3]. It is the second most common nosocomial infection in the intensive care unit (ICU) and the most common in mechanically ventilated patients [4, 5]. VAP rates range from 1.2 to 8.5 per 1,000 ventilator days and are reliant on the definition used for diagnosis [6]. Risk for VAP is greatest during the first 5 days of mechanical ventilation (3 %) with the mean duration between intubation and development of VAP being 3.3 days [1, 7]. This risk declines to 2 %/day between days 5 to 10 of ventilation, and 1 %/day thereafter [1, 8]. Earlier studies placed the attributable mortality for VAP at between 33–50 %, but this rate is variable and relies heavily on the underlying medical illness [1]. Over the years, the attributable risk of death has decreased and is more recently estimated at 9–13 % [9, 10], largely because of implementation of preventive strategies. Approximately 50 % of all antibiotics administered in ICUs are for treatment of VAP [2, 4]. Early onset VAP is defined as pneumonia that occurs within 4 days and this is usually attributed to antibiotic sensitive pathogens whereas late onset VAP is more likely caused by multidrug resistant (MDR) bacteria and emerges after 4 days of intubation [1, 4]. Thus, VAP poses grave implications in endotracheally intubated adult patients in ICUs worldwide and leads to increased adverse outcomes and healthcare costs. Independent risk factors for development of VAP are male sex, admission for trauma and intermediate underlying disease severity, with odds ratios (OR) of 1.58, 1.75 and 1.47–1.70, respectively [7].
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References:
American Thoracic Society, Infectious Diseases Society of America (2005) Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 171:388–416
Vincent JL, Bihari DJ, Suter PM et al (1995) The prevalence of nosocomial infection in intensive care units in Europe. JAMA 274:639–644
Chastre J, Fagon JY (2002) State of the art: ventilator-associated pneumonia. Am J Respir Crit Care Med 165:867–903
Hunter JD (2012) Ventilator associated pneumonia. BMJ 344(e3325):e3325
Afshari A, Pagani L, Harbarth S (2012) Year in review 2011: Critical care – infection. Crit Care 16:242–247
Skrupky LP, McConnell K, Dallas J, Kollef MH (2012) A comparison of ventilator-associated pneumonia rates as identified according to the National Healthcare Safety Network and American College of Chest Physicians Criteria. Crit Care Med 40:281–284
Rello J, Ollendorf D, Oster G et al (2002) Epidemiology and outcomes of ventilator-associated pneumonia in a large US database. Chest 122:2115–2121
Cook DJ, Walter SD, Cook RJ et al (1998) Incidence of and risk factors for ventilator-associated pneumonia in critically ill patients. Ann Int Med 129:433–440
Melsen WG, Rovers MM, Koeman M, Bonten MJM (2011) Estimating the attributable mortality of ventilator-associated pneumonia from randomized prevention studies. Crit Care Med 39:2736–2742
Melsen WG, Rovers MM, Groenwold RH et al (2013) Attributable mortality of ventilator-associated pneumonia: a meta-analysis of individual patient data from randomised prevention studies. Lancet Infect Dis 13:665–671
Zolfaghari PS, Wyncoll DL (2011) The tracheal tube: gateway to ventilator-associated pneumonia. Crit Care 15:310–317
Grgurich PE, Hudcova J, Lei Y, Sarwar A, Craven DE (2013) Diagnosis of ventilator-associated pneumonia: controversies and working toward a gold standard. Curr Opin Infect Dis 26:140–150
Mietto C, Pinciroli R, Patel N, Berra L (2013) Ventilator associated pneumonia: evolving definitions and preventive strategies. Respir Care 58:990–1007
Rocha LA, Marques Ribas R, da Costa Darini AL, Gontijo Filho PP (2013) Relationship between nasal colonization and ventilator-associated pneumonia and the role of the environment in transmission of Staphylococcus aureus in intensive care units. Am J Infect Control (in press)
Morris AC, Brittan M, Wilkinson TS et al (2011) C5a-mediated neutrophil dysfunction is RhoA-dependent and predicts infection in critically ill patients. Blood 117:5178–5188
Conway Morris A, Anderson N, Brittan M et al (2013) Combined dysfunctions of immune cells predict nosocomial infection in critically ill patients. Br J Anaesth 3:1–10
National Healthcare Safety Network (NHSN) (2013) July 2013 CDC/NHSN Protocol Clarifications Available at: http://www.cdc.gov/nhsn/PDFs/pscManual/10-VAE_FINAL.pdf Accessed Oct 2013
Klompas M (2013) Clinician’s Corner: Does this patient have ventilator-associated pneumonia? JAMA 297:1583–1593
Petersen IS, Aru A, Skødt V et al (1999) Evaluation of pneumonia diagnosis in intensive care patients. Scand J Infect Dis 31:299–303
Fàbregas N, Ewig S, Torres A et al (1999) Clinical diagnosis of ventilator associated pneumonia revisited: comparative validation using immediate post-mortem lung biopsies. Thorax 54:867–873
Johanson WG, Pierce AK, Sanford JP, Thomas GD (1972) Nosocomial respiratory infections with gram-negative bacilli. The significance of colonization of the respiratory tract. Ann Int Med 77:701–706
Pugin J, Auckenthaler R, Mili N, Janssens JP, Lew PD, Suter PM (1991) Diagnosis of ventilator-associated pneumonia by bacteriologic analysis of bronchoscopic and nonbronchoscopic “blind” bronchoalveolar lavage fluid. Am Rev Respir Dis 143:1121–1129
Shan J, Chen HL, Zhu JH (2011) Diagnostic accuracy of clinical pulmonary infection score for ventilator-associated pneumonia: a meta-analysis. Respir Care 56:1087–1094
Zilberberg MD, Shorr AF (2010) Ventilator-associated pneumonia: the clinical pulmonary infection score as a surrogate for diagnostics and outcome. Clin Infect Dis 1(1):S131–S135
Shorr AF, Cook D, Jiang X, Muscedere J, Heyland D (2008) Correlates of clinical failure in ventilator-associated pneumonia: insights from a large, randomized trial. J Crit Care 23:64–73
Singh N, Rogers P, Atwood CW, Wagener MM, Yu VL (2000) Short-course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit. A proposed solution for indiscriminate antibiotic prescription. Am J Respir Crit Care Med 162:505–511
Luna CM, Vujacich P, Niederman MS, Vay C, Gherardi C (1996) Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia. Chest 11:676–685
Canadian Critical Care Trials Group (2013) A randomized trial of diagnostic techniques for ventilator-associated pneumonia. N Engl J Med 355:2619–2630
Berton DC, Kalil AC, Cavalcanti M, Teixeira PJ (2012) Quantitative versus qualitative cultures of respiratory secretions for clinical outcomes in patients with ventilator-associated pneumonia Chocrane Database Syst Rev 1:CD006482
Auerbach DI, Staiger DO, Muench U, Buerhaus PI (2013) The nursing workforce in an era of health care reform. N Engl J Med 368:1470–1472
Hayashi Y, Morisawa K, Klompas M et al (2013) Toward improved surveillance: the impact of ventilator-associated complications on length of stay and antibiotic use in patients in intensive care units. Clin Infect Dis 56:471–477
Berton DC, Kalil AC, Teixeira PJ (2012) Quantitative versus qualitative cultures of respiratory secretions for clinical outcomes in patients with ventilator-associated pneumonia. Cochrane Database Syst Rev CD006482
Klompas M (2013) Complications of mechanical ventilation – the CDC's new surveillance paradigm. N Engl J Med 368:1472–1475
Masterton RG (2011) Antibiotic de-escalation. Crit Care Clin 27:149–162
Torres A, Ewig S, Lode H, Carlet J (2009) Defining, treating and preventing hospital acquired pneumonia: European perspective. Intensive Care Med 35:9–29
Walkey AJ, O’Donnell MR, Wiener RS (2011) Linezolid vs glycopeptide antibiotics for the treatment of suspected methicillin-resistant Staphylococcus aureus nosocomial pneumonia: a meta-analysis of randomized controlled trials. Chest 139:1148–1155
Munoz-Price LS, Weinstein RA (2008) Acinetobacter Infection. N Engl J Med 358:1271–1281
Martin-Loeches I, Deja M, Koulenti D et al (2013) Potentially resistant microorganisms in intubated patients with hospital-acquired pneumonia: the interaction of ecology, shock and risk factors. Intensive Care Med 39:672–681
Pasquale TR, Jabrocki B, Salstrom SJ et al (2013) Emergence of methicillin-resistant Staphylococcus aureus USA300 genotype as a major cause of late-onset nosocomial pneumonia in intensive care patients in the USA. Inter J Infect Dis 17:e398–e403
Capellier G, Mockly H, Charpentier C et al (2012) Early-onset ventilator-associated pneumonia in adults randomized clinical trial: comparison of 8 versus 15 days of antibiotic treatment. PloS one 7:e41290
Chastre J, Wolff M, Fagon J-Y et al (2003) Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial. JAMA 290:2588–2598
Dimopoulos G, Poulakou G, Pneumatikos IA, Armaganidis A, Kollef MH, Matthaiou DK (2013) Short- versus long-duration antibiotic regimens for ventilator-associated pneumonia: a systematic review and meta-analysis. Chest (in press)
Swoboda SM, Dixon T, Lipsett PA (2006) Can the clinical pulmonary infection score impact ICU antibiotic days ? Surg Infect (Larchmt) 7:331–339
Morris AC, Hay AW, Swann DG et al (2011) Reducing ventilator-associated pneumonia in intensive care: impact of implementing a care bundle. Crit Care Med 39:2218–2224
Alhazzani W, Almasoud A, Jaeschke R et al (2013) Small bowel feeding and risk of pneumonia in adult critically ill patients: a systematic review and meta-analysis of randomized trials. Crit Care 17:R127
Muscedere J, Rewa O, McKechnie K, Jiang X, Laporta D, Heyland DK (2011) Subglottic secretion drainage for the prevention of ventilator-associated pneumonia: a systematic review and meta-analysis. Crit Care Med 39:1985–1991
Morrow LE, Kollef MH (2010) Recognition and prevention of nosocomial pneumonia in the intensive care unit and infection control in mechanical ventilation. Crit Care Med 38:S352–S362
Youngquist P, Carroll M, Farber M et al (2007) Implementing a ventilator bundle in a community hospital. Jt Comm J Qual Patient Saf 33:219–225
Zilberberg MD, Shorr AF, Kollef MH (2009) Implementing quality improvements in the intensive care unit: Ventilator bundle as an example. Crit Care Med 37:305–309
Vallés J, Peredo R, Burgueño MJ et al (2013) Efficacy of single-dose antibiotic against early-onset pneumonia in comatose patients who are ventilated. Chest 143:1219–1225
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer International Publishing Switzerland and BioMed Central Ltd.
About this chapter
Cite this chapter
Kalanuria, A.A., Mirski, M., Ziai, W. (2014). Ventilator-associated Pneumonia in the ICU. In: Vincent, JL. (eds) Annual Update in Intensive Care and Emergency Medicine 2014. Annual Update in Intensive Care and Emergency Medicine, vol 2014. Springer, Cham. https://doi.org/10.1007/978-3-319-03746-2_6
Download citation
DOI: https://doi.org/10.1007/978-3-319-03746-2_6
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-03745-5
Online ISBN: 978-3-319-03746-2
eBook Packages: MedicineMedicine (R0)